A detailed history of Geode Capital Management, LLC transactions in Arvinas, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 1,541,737 shares of ARVN stock, worth $37.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,541,737
Previous 1,313,316 17.39%
Holding current value
$37.7 Million
Previous $54.2 Million 24.3%
% of portfolio
0.0%
Previous 0.01%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$24.46 - $40.4 $5.59 Million - $9.23 Million
228,421 Added 17.39%
1,541,737 $41 Million
Q1 2024

May 13, 2024

BUY
$36.38 - $52.31 $6.94 Million - $9.97 Million
190,689 Added 16.99%
1,313,316 $54.2 Million
Q4 2023

Feb 13, 2024

BUY
$14.19 - $42.33 $925,713 - $2.76 Million
65,237 Added 6.17%
1,122,627 $46.2 Million
Q3 2023

Nov 13, 2023

BUY
$19.64 - $28.21 $1.23 Million - $1.76 Million
62,416 Added 6.27%
1,057,390 $20.8 Million
Q2 2023

Aug 11, 2023

BUY
$21.73 - $31.43 $851,229 - $1.23 Million
39,173 Added 4.1%
994,974 $24.7 Million
Q1 2023

May 15, 2023

BUY
$26.15 - $37.26 $1.09 Million - $1.55 Million
41,507 Added 4.54%
955,801 $26.1 Million
Q4 2022

Feb 13, 2023

BUY
$32.47 - $57.24 $979,587 - $1.73 Million
30,169 Added 3.41%
914,294 $31.3 Million
Q3 2022

Nov 14, 2022

BUY
$41.87 - $57.99 $2.64 Million - $3.65 Million
62,993 Added 7.67%
884,125 $39.3 Million
Q2 2022

Aug 12, 2022

SELL
$36.01 - $74.24 $153,330 - $316,113
-4,258 Reduced 0.52%
821,132 $34.6 Million
Q1 2022

May 13, 2022

BUY
$60.27 - $81.57 $1.43 Million - $1.94 Million
23,770 Added 2.97%
825,390 $55.5 Million
Q4 2021

Feb 11, 2022

BUY
$65.85 - $96.21 $2.6 Million - $3.8 Million
39,491 Added 5.18%
801,620 $65.8 Million
Q3 2021

Nov 12, 2021

BUY
$73.2 - $107.87 $6.61 Million - $9.74 Million
90,295 Added 13.44%
762,129 $62.6 Million
Q2 2021

Aug 13, 2021

BUY
$60.45 - $84.26 $4.71 Million - $6.56 Million
77,862 Added 13.11%
671,834 $51.7 Million
Q1 2021

May 12, 2021

BUY
$58.19 - $91.37 $4.53 Million - $7.11 Million
77,854 Added 15.08%
593,972 $39.3 Million
Q4 2020

Feb 12, 2021

BUY
$20.19 - $84.93 $2.51 Million - $10.6 Million
124,465 Added 31.78%
516,118 $43.8 Million
Q3 2020

Nov 13, 2020

BUY
$22.99 - $36.34 $1.25 Million - $1.98 Million
54,510 Added 16.17%
391,653 $9.25 Million
Q2 2020

Aug 13, 2020

BUY
$29.88 - $56.74 $1.77 Million - $3.37 Million
59,317 Added 21.35%
337,143 $11.3 Million
Q1 2020

May 14, 2020

BUY
$33.0 - $54.5 $779,262 - $1.29 Million
23,614 Added 9.29%
277,826 $11.2 Million
Q4 2019

Feb 13, 2020

BUY
$15.39 - $44.38 $1.12 Million - $3.24 Million
73,088 Added 40.35%
254,212 $10.4 Million
Q3 2019

Nov 12, 2019

BUY
$21.55 - $27.61 $130,226 - $166,847
6,043 Added 3.45%
181,124 $3.9 Million
Q2 2019

Aug 14, 2019

BUY
$15.96 - $23.8 $931,218 - $1.39 Million
58,347 Added 49.98%
175,081 $3.85 Million
Q1 2019

May 14, 2019

BUY
$13.55 - $23.79 $689,654 - $1.21 Million
50,897 Added 77.31%
116,734 $1.72 Million
Q4 2018

Feb 13, 2019

BUY
$11.19 - $18.56 $736,716 - $1.22 Million
65,837 New
65,837 $846,000

Others Institutions Holding ARVN

About ARVINAS, INC.


  • Ticker ARVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,205,300
  • Market Cap $1.3B
  • Description
  • Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...
More about ARVN
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.